Utility of indices using C-peptide levels for indication of insulin therapy to achieve good glycemic control in Japanese patients with type 2 diabetes
Open Access
- 4 January 2011
- journal article
- research article
- Published by Wiley in Journal of Diabetes Investigation
- Vol. 2 (4), 297-303
- https://doi.org/10.1111/j.2040-1124.2010.00096.x
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Diagnosis and Classification of Diabetes MellitusDiabetes Care, 2010
- Standards of Medical Care in Diabetes—2010Diabetes Care, 2010
- Functional Assessment of Pancreatic β-Cell Area in HumansDiabetes, 2009
- Nutrition Education Improves Metabolic Outcomes among Older Adults with Diabetes Mellitus: Results from a Randomized Controlled TrialPreventive Medicine, 2002
- U.K. prospective diabetes study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease. U.K. Prospective Diabetes Study GroupDiabetes, 1995
- Reproducibility of βCell Function Estimates in Non-Insulin-Dependent Diabetes MellitusDiabetes Care, 1987
- The difficult choice of treatment for poorly controlled maturity onset diabetes: tablets or insulin?BMJ, 1984
- Serum C-Peptide and IRI Levels after Administration of Glucagon and Glucose in Non-Insulin-Dependent DiabeticsHormone and Metabolic Research, 1982
- Prevalence of residual B-cell function in insulin-treated diabetics evaluated by the plasma C-peptide response to intravenous glucagonDiabetologia, 1977
- C-peptide response to glucagon. A test for the residual beta-cell function in diabetes mellitusDiabetes, 1977